Pathologic Bone Resorption and New Bone Formation in Inflammatory Arthritis

• 1. Ritchlin CT
  2. Coates LC
  3. Mease PJ
  4. van der Heijde D
  5. Rahman P
  Effects of Guselkumab on Structural Damage Progression in Patients with Active Psoriatic Arthritis.; Advances in therapy. 2026 May 05.
• 1. Scher JU
  2. McInnes IB
  3. Soriano ER
  4. Merola JF
  5. Bird P
  6. Chandran V
  7. Cheng E
  8. Reynoso E
  9. Chen W
  10. Li M
  11. Gensler LS
  12. Mease PJ
  13. Ritchlin CT
  Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From the Phase 2a, Multicenter, Randomized, Double-Blind, Proof-of-Concept AFFINITY Study.; Arthritis & rheumatology (Hoboken, N.J.). 2026 Mar 25.
• 1. Peng Y
  2. Kenney HM
  3. Lydon S
  4. de Mesy Bentley KL
  5. Xing L
  6. Korman BD
  7. Ritchlin CT
  8. Schwarz EM
  Telocyte Deletion is Associated with Loss of Lymphatic Drainage and Exacerbation of Inflammatory-Erosive Arthritis in Mice.; Arthritis & rheumatology (Hoboken, N.J.). 2026 Mar 16.
• 1. Gossec L
  2. Coates LC
  3. Landewé RBM
  4. Mease PJ
  5. Merola JF
  6. Ritchlin CT
  7. Tanaka Y
  8. Asahina A
  9. Proft F
  10. Goldammer N
  11. Manente M
  12. Ink B
  13. Bajracharya R
  14. Coarse J
  15. McInnes IB
  Bimekizumab safety and efficacy in patients with psoriatic arthritis: 3-year results from two phase 3 studies.; Rheumatology (Oxford, England). 2026 Mar 16.

May 8, 2026
Dr. Garcia-Hernandez, PhD to Receive the Women of Distinction Award

May 8, 2026
Dr. John Looney Named a JACI 2026 Outstanding Reviewer

April 13, 2026
Mentee of Dr. Jennifer Barnas Awarded Rochester Academy of Science Student Grant

February 6, 2026
Dr. Katherine Herman Presents Medical Grand Rounds

January 23, 2026
Dr. Theresa Bingemann Presents at the AAAAI Program Directors Assembly Winter Meeting

All News »